• (+)-Bicuculline: Technical Use Guide for GABAA Antagonist St

  2026-05-25

  (+)-Bicuculline is a well-established GABAA receptor antagonist used to dissect GABAergic signaling and modulate synaptic NMDA receptor activity in neuroscience research. It is most appropriate for acute in vitro and in vivo experiments requiring direct inhibition of GABAA-mediated neurotransmission, but is not suitable for diagnostic or clinical use. Adhering to solubility and storage protocols is essential for reliable outcomes.

• Redefining mRNA Delivery: Strategic Advances with EZ Cap EGF

  2026-05-25

  Explore how EZ Cap EGFP mRNA 5-moUTP sets a new standard in mRNA delivery and translational research, integrating advanced chemical modifications for optimal gene expression, immune evasion, and in vivo imaging. This thought-leadership article bridges mechanistic innovations with actionable guidance for researchers, leveraging recent breakthroughs in mRNA loading and nanoparticle formulation.

• Stereochemical Modification of Degarelix: Impact on GnRH Ant

  2026-05-24

  This study investigates how introducing racemic 3-(2-methoxy-5-pyridyl)-alanine at position 3 of Degarelix alters its potency and duration as a GnRH receptor antagonist. The findings highlight the critical influence of stereochemistry on antagonist efficacy and provide a structure–activity framework for optimizing hormone therapy agents.

• Calpeptin: Potent Calpain Inhibitor for Pulmonary Fibrosis R

  2026-05-23

  Calpeptin is a nanomolar calpain inhibitor that enables precise modulation of calcium-dependent cysteine protease activity in fibrosis and inflammation models. Its robust efficacy and specificity make it a gold-standard tool for pulmonary fibrosis research, as demonstrated in in vitro and in vivo studies.

• NF 340: Selective P2Y11 Antagonist for Advanced Immunology R

  2026-05-22

  NF 340 is a potent, selective P2Y11 antagonist empowering researchers to dissect GPCR signaling and inflammation pathways with precision. Its validated use in reversing QPRT-driven breast cancer invasiveness sets it apart as a critical tool for translational immunology and cancer biology studies.

• Gibberellin-Induced Autophagic Degradation of DELLA Proteins

  2026-05-22

  Zhang et al. reveal that gibberellin promotes seed germination and skotomorphogenesis in Arabidopsis by triggering ATG8-dependent autophagic degradation of DELLA proteins under nutrient starvation. This mechanism operates alongside the classic 26S proteasome pathway, highlighting a new layer of hormonal regulation in plant development with implications for stress adaptation.

• In Vitro Efficacy of Midecamycin Against Clinical Bacteria

  2026-05-21

  This article reviews the in vitro antibacterial activity of midecamycin, an acetoxy-substituted macrolide antibiotic, as reported in a foundational 1983 study. The research systematically defines midecamycin’s potency and spectrum, highlighting its strengths against Gram-positive pathogens and its limitations against Gram-negative bacteria and erythromycin-resistant strains, with practical implications for antibiotic research workflows.

• Trypsin Serine Protease: Precision in Cell Biology Workflows

  2026-05-21

  Trypsin (BA5744) from APExBIO redefines proteolytic workflow precision, offering high solubility and consistent activity for complex research needs. This article navigates real-world applications, protocol enhancements, and troubleshooting tips for leveraging this serine protease in modern cell biology and translational research.

• Decitabine Primes CD8+ T Cells to Enhance Anti–PD-1 Tumor Re

  2026-05-20

  This study demonstrates that low-dose decitabine treatment before anti–PD-1 therapy selectively expands and sustains progenitor exhausted CD8+ T cells in tumors. By remodeling the epigenetic landscape and maintaining JunD activity, decitabine enhances antitumor efficacy, offering a new mechanistic rationale for improving checkpoint blockade outcomes.

• Angiotensin 1/2 (5-7): Translational Gateways in RAS and Vir

  2026-05-20

  This article explores how Angiotensin 1/2 (5-7), a key vasoconstrictor peptide, is reshaping translational research across cardiovascular and viral pathogenesis fields. We detail mechanistic underpinnings, experimental strategies, and evolving clinical implications—bridging hypertension research with the emerging interface of SARS-CoV-2 biology.

• Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) in Ferro

  2026-05-19

  Leverage Gramine as a precision tool for dissecting ferroptosis and ubiquitination pathways in triple-negative breast cancer models. This article delivers protocol-driven guidance, troubleshooting strategies, and insights from recent mechanistic breakthroughs—empowering cancer biology researchers with actionable workflows.

• DiscoveryProbe™ Metabolism-related Compound Library: Technic

  2026-05-19

  The DiscoveryProbe™ Metabolism-related Compound Library provides researchers with a rigorously validated set of 493 small molecules for advanced metabolism research, including metabolic enzyme inhibition and pathway modulation. This resource is optimized for in vitro and ex vivo workflows but is not intended for clinical or in vivo studies.

• Hexetidine (NSC-17764): Oral Antimicrobial Benchmarks & Prot

  2026-05-18

  Hexetidine (NSC-17764) is a broad-spectrum antimicrobial agent effective against key oral pathogens and Candida albicans. Its primary mechanism involves membrane disruption, with defined MIC and clinical mouthwash concentrations. Protocol integration and limitations are clarified for laboratory and clinical use.

• BMS-345541 Hydrochloride: Redefining Selectivity in IKK Inhi

  2026-05-18

  Explore how BMS-345541 hydrochloride advances IKK inhibitor research through allosteric selectivity, translational insight, and unique applications in inflammation and T-ALL. This article offers a deeper, practical perspective grounded in the latest scientific evidence.

• Deep Learning and iPSC-CMs Advance Cardiotoxicity Screening

  2026-05-17

  This study demonstrates a scalable approach for early detection of cardiotoxic compounds by integrating deep learning with high-content imaging of iPSC-derived cardiomyocytes. The method enables efficient phenotypic screening, addressing key limitations of traditional cell models in drug safety assessment.

452 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page